Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quan Yang

Showing results (1131-1140 of 1,145) with videos related to

Pageof 115
Sort By:
Hepatology (Baltimore, Md.)|February 5, 2025
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stagesDa-Long Yang, Lin Ye, Fan-Jian Zeng, et al.
Nature Communications|June 6, 2020
Whole-genome resequencing of wild and domestic sheep identifies genes associated with morphological and agronomic traitsXin Li, Ji Yang, Min Shen, et al.
Liver Cancer|January 19, 2026
Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE006)Liang Ma, Da-Long Yang, Teng-Meng Zhong, et al.
Liver Cancer|June 11, 2025
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter StudyDa-Long Yang, Ning Peng, Jun-Liang Nong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025Robert I Haddad, Lindsay Bischoff, Megan Applewhite, et al.
JAMA Surgery|February 28, 2019
Clinical Outcomes After Unilateral Adrenalectomy for Primary AldosteronismWessel M C M Vorselaars, Sjoerd Nell, Emily L Postma, et al.
Molecular Biology and Evolution|September 17, 2020
Historical Introgression from Wild Relatives Enhanced Climatic Adaptation and Resistance to Pneumonia in SheepYin-Hong Cao, Song-Song Xu, Min Shen, et al.
The Laryngoscope|October 7, 2018
International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic dataChe-Wei Wu, Gianlorenzo Dionigi, Marcin Barczynski, et al.
Liver Cancer|July 11, 2026
Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective StudyLin Ye, Guo-Xing Liu, Da-Long Yang, et al.
Current Biology : CB|August 22, 2020
Paternal Origins and Migratory Episodes of Domestic SheepJuan Deng, Xing-Long Xie, Dong-Feng Wang, et al.
Pageof 115

Showing results (1131-1140 of 1,145) with videos related to

Sort By:
Pageof 115
Hepatology (Baltimore, Md.)|February 5, 2025
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stagesDa-Long Yang, Lin Ye, Fan-Jian Zeng, et al.
Nature Communications|June 6, 2020
Whole-genome resequencing of wild and domestic sheep identifies genes associated with morphological and agronomic traitsXin Li, Ji Yang, Min Shen, et al.
Liver Cancer|January 19, 2026
Prognostic Usefulness of Clinical Complete Response after PD-1 Inhibitor-Based Combination Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE006)Liang Ma, Da-Long Yang, Teng-Meng Zhong, et al.
Liver Cancer|June 11, 2025
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter StudyDa-Long Yang, Ning Peng, Jun-Liang Nong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025Robert I Haddad, Lindsay Bischoff, Megan Applewhite, et al.
JAMA Surgery|February 28, 2019
Clinical Outcomes After Unilateral Adrenalectomy for Primary AldosteronismWessel M C M Vorselaars, Sjoerd Nell, Emily L Postma, et al.
Molecular Biology and Evolution|September 17, 2020
Historical Introgression from Wild Relatives Enhanced Climatic Adaptation and Resistance to Pneumonia in SheepYin-Hong Cao, Song-Song Xu, Min Shen, et al.
The Laryngoscope|October 7, 2018
International neuromonitoring study group guidelines 2018: Part II: Optimal recurrent laryngeal nerve management for invasive thyroid cancer-incorporation of surgical, laryngeal, and neural electrophysiologic dataChe-Wei Wu, Gianlorenzo Dionigi, Marcin Barczynski, et al.
Liver Cancer|July 11, 2026
Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective StudyLin Ye, Guo-Xing Liu, Da-Long Yang, et al.
Current Biology : CB|August 22, 2020
Paternal Origins and Migratory Episodes of Domestic SheepJuan Deng, Xing-Long Xie, Dong-Feng Wang, et al.
Pageof 115